PAOG Welcome To Penny Land - Now $0.10?

 

February 4, 2021 -- InvestorsHub NewsWire -- via pennymillions -- First PAO Group, Inc, (USOTC: PAOG), with its proprietary, U.S. Patent backed CBD pharmaceutical treatment for Chronic Obstructive Pulmonary Disorder (COPD) called RespRx caught the #BioWar Reddit trend and the sub penny PPS started to move up. Then GW Pharma (GWPH) got priced at $7.2 billion for an acquisition by Jazz Pharmaceuticals (JAZZ) bringing even more attention to PAOG and now the PPS has broken through $0.01. What’s next? $0.10.

PAOG reaching a $0.10 PPS could happen. The company has revenue. PAOG just announced it anticipates reporting $50,000 for Q4 2020 as part of a $300,000 contract. Today the company announced plans to expand revenue with the introduction of new CBD Nutraceuticals. And of course there is the long-term value of a U.S. Patent backed CBD pharmaceutical.

PAOG has broken through all resistance trading well above all moving averages and setting new 52-week high records one after another. Some intermittent profit taking along the way may be the only thing to make a PPS rise hesitate along the way. If a #BioWar Reddit type trend continues, even $0,10 could be a number soon in the rear view mirror.

Source - https://www.pennymillions.com/blog/paog-welcome-to-penny-land-now-010

Other stocks on the move - PURA, ALKM, and USMJ

 

SOURCE: pennymillions